제품 세부정보
Product Overview
Human IL-9 ELISA Kit is a ready-to-use immunoassay kit, specifically designed to quantitate natural and recombinant human IL-9 that is present in biological samples, such as serum, plasma, and cell culture supernatants. Our ELISA Kit provides several benefits:
- Standards to calibrate with NIBSC/WHO standards for comparable results.
- Fully validation in biologic samples for detection range, sensitivity, inter- and intra-plate CV, recovery, dilution linearity, specificity, and matrix effects to ensure reliable results according to ICH M10 guideline.
- High-quality antibody pairs and protein standards, along with rigorous quality control, to guarantee consistent results across different batches.
- Ready-to-use reagents to save assay time.
Product Specifications
Assay TypeSandwich-ELISAAnalyteIL-9Format96-wells plate breakable into 12 x 8 wells stripsReactivityHumanSensitivity20 pg/mLAssay Time2.75 hrSample volume50 μLRange31.25 pg/mL-2000 pg/mLSample TypeFor the quantitative determination of human IL-9, plasma and cell supernatant.Elevate your research experience with our Cytokine/Biomarker Detection Kits, where accuracy, reliability, and ease of use are converging to deliver exceptional results.
Application
The kit is developed for quantitative detection of natural and recombinant human IL-9 in serum, plasma and cell culture supernatants.
It is for research use only.
Workflow

Storage
Keep the unopened kit stored at 2-8 °C. Avoid using the kit beyond its expiration date. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
Materials Provided
IDComponentsSizeCEA266-C01Pre-coated Anti-IL-9 Antibody Microplate1 plateCEA266-C02Human IL-9 Standard40 ng/mL×2CEA266-C03Biotin-Anti-IL-9 Antibody Con. Solution100 μLCEA266-C04Biotin-Antibody Dilution Buffer15 mLCEA266-C05Streptavidin-HRP Con. Solution500 μLCEA266-C06Streptavidin-HRP Dilution Buffer15 mLCEA266-C0720× Washing Buffer50 mLCEA266-C08Sample Dilution Buffer15 mL×2CEA266-C09Substrate Solution12 mLCEA266-C10Stop Solution6 mLACRO Quality Management System
고객님도 확인한 상품
데이터 표시
Typical Data
Please refer to DS document for the assay protocol.

For each experiment, a standard curve needs to be set for each microplate, and the specific OD value may vary depending on different laboratories, testers, or equipment. The following example data is for reference only. The sample concentration was calculated based on the results of the standard curve. The minimum detectable concentration of IL-9 is less than 20 pg/mL.
Sample Values
Cell Culture Supernatant: Human peripheral blood mononuclear cells (PBMCs) (1.5 x 10⁶ cells/mL) were cultured in complete RPMI 1640 medium containing 10% fetal bovine serum, 2 mM L-glutamine, and antibiotic supplements (penicillin 100 U/mL with streptomycin sulfate 100 μg/mL). PBMC cells were either left unstimulated or stimulated with 10 μg/mL PHA and cultured for 3 to 5 days. Cell supernatants of cultured cells were collected on day 3 and day 5, stored at≤-20°C. Subsequent analysis involved quantitative measurement of IL-9 concentrations in collected culture supernatants is conducted by using standardized immunoassays.

Cell Culture Supernatant 2: Human peripheral blood mononuclear cells (PBMCs) (1.5 x 10⁶ cells/mL) were cultured in complete RPMI 1640 medium containing 10% fetal bovine serum, 2 mM L-glutamine, and antibiotic supplements (penicillin 100 U/mL with streptomycin sulfate 100 μg/mL). PBMC cells were either left unstimulated or stimulated with 10 ng/mL PMA and 500 ng/mL of Ionomycin Calcium salt, cultured for 2 days. Cell supernatants of cultured cells were collected on day 1 and day 2, stored at≤-20°C. Subsequent analysis involved quantitative measurement of IL-9 concentrations in collected culture supernatants is conducted by using standardized immunoassays.

Intra-Assay Statistics
Ten replicates of each of 3 samples containing different IL-9 concentrations were tested in one assay. Acceptable criteria: CV<10%.

Inter-Assay Statistics
Three samples containing different concentrations of IL-9 were tested in independent assays. Acceptable criteria: CV<15%.

Recovery
Recombinant IL-9 was spiked into 3 human serum samples, and then analyzed. The average recovery of IL-9 for serum samples is 109.2%.

사용자 리뷰 댓글 남기기

프론티어 진행
- 영어 이름:
Interleukin-9
- 카테고리:
- 상장 의약품 수:
0 상세
- 임상 의약품 수:
1 상세
- 최고 개발 단계:
Phase 2 Clinical
전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521



















